RxDoctor Payments Data

Melinda Nieman, MD

Psychiatry · Hamilton, OHNPI 1861595050

Payments from drug & device makers

$3,137in general payments, 2019–2025

Across 216 payments — averaging $14.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$488
  • AbbVie$429
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$367
  • Vanda Pharmaceuticals Inc.$366
  • Teva Pharmaceuticals USA, Inc.$318
  • Lundbeck LLC$268
  • plus $902 from 6 others

What the payments were for

  • Food & beverage$3,137100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,137 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio

Medicare billing

Part B allowed, 2024
$11,806
Medicare patients
23
Services billed
106

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate53$172,630
Abilify MaintenaAripiprazole45$123,200
Invega TrinzaPaliperidone Palmitate12$97,477
UzedyRisperidone22$78,364
CaplytaLumateperone Tosylate22$51,478
Risperdal ConstaRisperidone Microspheres26$45,310
LybalviOlanzapine/Samidorphan Malate27$42,101
VraylarCariprazine Hcl41$34,340
Paliperidone ErPaliperidone108$25,376
Risperidone ErRisperidone Microspheres18$24,639
Aripiprazole242$20,706
RexultiBrexpiprazole14$19,013
Clozapine625$14,557
Haloperidol Decanoate66$3,945
Bupropion XlBupropion Hcl337$3,239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$239$315,41791 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$488$142,21259 claims
Teva Pharmaceuticals USA, Inc.Uzedy$318$78,36422 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$367$51,47822 claims
Alkermes, Inc.Lybalvi$260$42,10127 claims
AbbVieVraylar$429$34,34041 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,119 psychiatry providers in Ohio.

Other psychiatry in Hamilton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →